What You Should Know:
- Walgreens Boots Alliance (WBA) has announced a definitive agreement to be acquired by an entity affiliated with Sycamore Partners, a private equity firm specializing in retail, consumer, and distribution-related investments.
- The total value of the transaction is estimated to be up to $23.7B.
Deal Structure and Shareholder Value
WBA shareholders will receive $11.45 per share in cash at closing, along with a non-transferable right (DAP Right) to
Read More
Walgreens
Walgreens Launches Specialty Pharmacy for Complex Conditions
What You Should Know:
- Walgreens, a leading pharmacy chain, is making a significant push into the specialty pharmacy market with the launch of "Walgreens Specialty Pharmacy."
- The new $25B initiative expands access to care for patients with complex, chronic conditions while driving profitability for the company.
Walgreens Specialty Pharmacy: A Holistic Approach
Walgreens Specialty Pharmacy aims to break down barriers within the healthcare system. By leveraging
Read More
Walgreens Sells $1.85B of AmerisourceBergen Shares, Reduces Stake by 16%
What You Should Know:
Walgreens Boots Alliance announces the sale of shares of AmerisourceBergen Corporation valued at $1.85B for debt paydown and general corporate purposes.Walgreens Boots Alliance’s ownership stake of AmerisourceBergen’s common stock has not been impacted but is expected to decrease by to approximately 16 percent.
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
Opioid Settlements are Making Headlines; Is Now The Time to Soften Guidelines?
The United States only represents five percent of the world’s population; however, Americans consume 80 percent of the world’s opioids.1 The U.S. is the world’s leader in the use of opioid medications to cope with physical and emotional difficulties. And the recent Walgreens and Wal-Mart multi-state opioid settlement agreement disclosures have only hammered home the point. America continues to have an opioid addiction problem.
In light of all these circumstances, the recent CDC
Read More
Home Healthcare Market is Expected to Reach $340.2B
What You Should Know:
- Home Healthcare market in terms of revenue was estimated to be worth $226 Billion in 2022 and is poised to reach $340.2 billion by 2027, growing at a CAGR of 8.5% from 2022 to 2027 according to a latest report published by MarketsandMarkets™.
- The report reveals growth in this market is mainly driven by rapid growth in the elderly population, and the rising incidence of chronic diseases.
Rising Demand for Home-Health Services & Solutions
The home
Read More
8 Executive Pharmacy Predictions/Trends to Watch in 2023
Frank Harvey, CEO at Surescripts
Community pharmacists trusted to deliver care: In 2023, pharmacists will play an integral role as part of the team managing patient care for diseases like diabetes, hypertension, or multiple comorbidities. And to support this work, I predict that we will see more activity between payers, pharmacists, the government and technology organizations to ensure that pharmacists are able to perform these important activities and be reimbursed for their work.
Greg
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
PwC’s Health Services 2023 Deals Outlook – Volume Remains Resilient Against Headwinds
What You Should Know:
- While megadeals, trading multiples and overall deal values in the health services sector have not been immune to interest rate hikes and recessionary fears, PwC’s 2023 Health Services Deals Outlook report released recently forecasts a strong year ahead.
- Increasing transaction volumes and players embracing value-based care—coupled with large levels of corporate cash and private equity dry powder—are leading to continued expansion for deal volumes in 2023.
Trends
Read More
Walgreens Find Care Offers Dementia Patients with Personalized Playlists
What You Should Know:
- Music Health Inc. announced that its music wellness app, Vera, is now available through Walgreens Find Care® to provide people living with different forms of dementia with convenient and affordable access to personalized music from their computers and smart devices.
- Vera is a new app that supports caregivers by offering the person in their care a custom-made “soundtrack of their lives” that can
Read More
